ARTICLE | Clinical News
geneX regulatory update
March 9, 2009 7:00 AM UTC
China's State Food and Drug Administration (SFDA) approved Biocomposites' geneX as a bone graft substitute. The company said it would begin marketing the fully resorbable synthetic biomaterial with a ...